ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: McGrath RentCorp (Nasdaq – MGRC), Science 37 Holdings, Inc. (Nasdaq – SNCE), Eagle Bulk Shipping Inc. (NYSE - EGLE), Cerevel Therapeutics Holdings, Inc. (Nasdaq –

BALA CYNWYD, Pa., Jan. 29, 2024 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.

McGrath RentCorp (Nasdaq – MGRC)

Under the terms of the agreement, McGrath RentCorp will be acquired by WillScot Mobile Mini Holdings Corp. (“WillScot Mobile Mini”) (Nasdaq - WSC). McGrath RentCorp shareholders will receive for each of their shares either $123.00 in cash or 2.8211 shares of WillScot Mobile Mini common stock, as determined pursuant to the election and allocation procedures in the merger agreement under which 60% of McGrath’s outstanding shares will be converted into the cash consideration and 40% of McGrath’s outstanding shares will be converted into the stock consideration. The transaction values McGrath RentCorp at an enterprise value of $3.8 billion, including approximately $800 million of net debt. The investigation concerns whether the McGrath RentCorp Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether WillScot Mobile Mini is paying fair value to shareholders of the Company.

Additional information can be found at https://www.brodskysmith.com/cases/mcgrath-rentcorp-nasdaq-mgrc/.

Science 37 Holdings, Inc. (Nasdaq – SNCE)

Under the terms of the agreement, Science 37 will be acquired by eMed, LLC (“eMed”). Science 37 stockholders will receive $5.75 in cash for each share of the Company’s stock. The investigation concerns whether the Science 37 Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether eMed is paying fair value to shareholders of the Company.

Additional information can be found at https://www.brodskysmith.com/cases/science-37-holdings-inc-nasdaq-snce/.

Eagle Bulk Shipping Inc. (NYSE - EGLE)

Under the terms of the agreement, Eagle Bulk will be acquired by Star Bulk Carriers Corp. (“Star Bulk”) (Nasdaq - SBLK). Eagle shareholders will receive 2.6211 shares of Star Bulk common stock for each share of Eagle common stock owned. This represents a total consideration of approximately $52.60 per share. Upon the close of the transaction, Star Bulk and Eagle shareholders will own approximately 71% and 29% of the combined company on a fully diluted basis, respectively. The investigation concerns whether the Eagle Bulk Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether Star Bulk is paying fair value to shareholders of the Company, as well as the dilution to the Company’s shareholders in the combined company.

Additional information can be found at https://www.brodskysmith.com/cases/eagle-bulk-shipping-inc-nyse-egle/.

Cerevel Therapeutics Holdings, Inc. (Nasdaq – CERE)

Under the terms of the Merger Agreement, Cerevel will be acquired by AbbVie Inc. (NYSE - ABBV). Under the terms of the agreement, Cerevel stockholders will receive $45.00 in cash for each share of the Company’s stock for an equity value of approximately $8.7 billion. The investigation concerns whether the Cerevel Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether AbbVie is paying fair value to shareholders of the Company.

Additional information can be found at https://www.brodskysmith.com/cases/cerevel-therapeutics-holdings-inc-nasdaq-cere/.

Brodsky & Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.

 


Primary Logo

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.